Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsReceivables - Net
Ratios

Outlook Therapeutics (OTLK) Leases (2016 - 2025)

Outlook Therapeutics (OTLK) has disclosed Leases for 8 consecutive years, with $212413.0 as the latest value for Q4 2025.

  • On a quarterly basis, Leases fell 19.18% to $212413.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $212413.0, a 19.18% decrease, with the full-year FY2025 number at $225508.0, changed N/A from a year prior.
  • Leases was $212413.0 for Q4 2025 at Outlook Therapeutics, down from $225508.0 in the prior quarter.
  • In the past five years, Leases ranged from a high of $262822.0 in Q4 2024 to a low of $212413.0 in Q4 2025.